Literature DB >> 1975157

Continuous acidity monitoring in the study of gastric antisecretory drugs: pH or antilog transformation of pH, mean or median?

G S Mela1, V Savarino, A Sumberaz, G Bonifacino, P Zentilin, G Villa, E Caputo.   

Abstract

The expression of gastric acidity as pH or antilog transformation of pH and the use of the mean or the median as the better summary variable are among the major problems concerning the assessment of antisecretory drugs' effects by means of continuous intraluminal pH monitoring. In this study, we reviewed data deriving from 23 normal subjects, 69 asymptomatic duodenal ulcer patients treated with bedtime (52) or twice daily (17) doses of H2-antagonists, and 10 H2-receptor blocker nonresponders. The whole group underwent continuous 24-h acidity monitoring, and the arithmetic mean and median were calculated on each individual pH and pH antilog transformed profile. One-way analysis of variance and Kruskall-Wallis test were used for statistical comparison between the four subgroups studied. The greatest discrimination between them was obtained when using the mean of pHs [p(F) approximately 0, p[KW] = 2.10(-12)), instead of the median of pHs (p[F] = 8.10(-8), p[KW] = 7.10(-8)). The antilog transformation of pH did not improve the results. It can be concluded that the use of pH to express gastric acidity and the choice of the mean to summarize the drug-related profiles provides a better characterization of the acidity behavior than would the antilog transformation of pHs and the median.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975157

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

1.  Mealtime versus nighttime acid inhibition. A clinical pharmacological study with ranitidine.

Authors:  V Savarino; G S Mela; P Zentilin; S Vigneri; P Cutela; R Mele; F Di Mario
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

2.  Circadian gastric acidity and Helicobacter pylori infection in patients with chronic pancreatitis.

Authors:  V Savarino; G S Mela; P Zentilin; C Mansi; M R Mele; N Pandolfo; V Pugliese; S Vigneri
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 3.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

4.  Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum.

Authors:  V Savarino; G S Mela; P Zentilin; M R Mele; L Lapertosa; R Patetta; E Dallorto; A Vassallo; C Mansi; S Vigneri; G Celle
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

5.  Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer.

Authors:  V Savarino; G S Mela; P Zentilin; P Cutela; M R Mele; D Perilli; A Vassallo; A Zambotti; C Mansi; G Celle
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

6.  Time pattern of gastric acidity in Barrett's esophagus.

Authors:  V Savarino; G S Mela; P Zentilin; M R Mele; C Mansi; A C Remagnino; S Vigneri; A Malesci; M Belicchi; G Lapertosa; G Celle
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

7.  Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy.

Authors:  V Savarino; G S Mela; P Zentilin; P Cutela; M R Mele; S Vigneri; G Celle
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.